News

Article

Rheumatoid Arthritis Quiz: TNF Inhibitors

Author(s):

Ingrid Torjesen

How well do patients with rheumatoid arthritis adhere to treatment with a TNF inhibitor and how likely and long lasting is remission? Test your knowledge with this quiz.

Is the following statement true or false?

Rheumatoid arthritis patients treated with tumor necrosis factor inhibitors (TNFis) are twice as likely to achieve remission compared with those treated with conventional synthetic disease-modifying medications (csDMARDs).


Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
4 experts are featured in this series.
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Skin of Color Savvy: The Art and Science of Treating Patients of Color
3 experts are featured in this series.
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Related Content
Ya-Chu Tsai, Department of Dermatology, Far Eastern Memorial Hospital, Taiwan
January 10th 2025

Meta-Analysis Confirms Efficacy of Small Molecules for Psoriatic Arthritis

Victoria Johnson
Diabetes Dialogue: Leveraging Smart Algorithms for Insulin Optimization with Eran Atlas | Image Credit: HCPLive
January 6th 2025

Diabetes Dialogue: Leveraging Smart Algorithms for Insulin Optimization with Eran Atlas

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
Atumelnant Reduces Key CAH Biomarkers, Hits Primary Phase 2 Endpoint | Image Credit: Crinetics Pharmaceuticals
January 10th 2025

Atumelnant Reduces Key CAH Biomarkers, Hits Primary Phase 2 Endpoint

Connor Iapoce
Skin of Color Savvy: Itch in Skin of Color, with Andrew Alexis, MD, MPH, and Shawn Kwatra, MD
January 6th 2025

Skin of Color Savvy: Itch in Skin of Color, with Andrew Alexis, MD, MPH, and Shawn Kwatra, MD

Andrew F Alexis, MD, MPH Shawn Kwatra, MD
Bayer Submits Finerenone Application to FDA for Treatment of Heart Failure | Image Credit: US Food and Drug Administration
January 10th 2025

Bayer Submits Finerenone Application to FDA for Treatment of Heart Failure

Connor Iapoce
Early Control of Rheumatoid Arthritis Improves Hemostatic Imbalance
January 10th 2025

Early Control of Rheumatoid Arthritis Improves Hemostatic Imbalance

Victoria Johnson
© 2025 MJH Life Sciences

All rights reserved.